| Genetic and epigenetic events generate multiple pathways in colorectal cancer progression M Pancione, A Remo, V Colantuoni Pathology research international 2012, 2012 | 231 | 2012 |
| MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer T Colangelo, A Fucci, C Votino, L Sabatino, M Pancione, C Laudanna, ... Neoplasia 15 (9), 1086-1099, 2013 | 160 | 2013 |
| Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis M Pancione, G Giordano, A Remo, A Febbraro, L Sabatino, E Manfrin, ... Journal of immunology research 2014, 2014 | 121 | 2014 |
| UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression L Sabatino, A Fucci, M Pancione, V Carafa, A Nebbioso, C Pistore, ... Oncogene 31 (49), 5061-5072, 2012 | 109 | 2012 |
| Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions G Giordano, M Pancione, N Olivieri, P Parcesepe, M Velocci, T Di Raimo, ... World journal of gastroenterology 23 (32), 5875, 2017 | 92 | 2017 |
| Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome M Pancione, L Sabatino, A Fucci, V Carafa, A Nebbioso, N Forte, ... PLoS One 5 (12), e14229, 2010 | 90 | 2010 |
| Reduced β-catenin and peroxisome proliferator–activated receptor–γ expression levels are associated with colorectal cancer metastatic progression: correlation with tumor … M Pancione, N Forte, L Sabatino, E Tomaselli, D Parente, A Febbraro, ... Human pathology 40 (5), 714-725, 2009 | 74 | 2009 |
| Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer T Colangelo, G Polcaro, P Ziccardi, B Pucci, L Muccillo, M Galgani, ... Cell death & disease 7 (2), e2120-e2120, 2016 | 73 | 2016 |
| Morphology and molecular features of rare colorectal carcinoma histotypes A Remo, M Fassan, A Vanoli, LR Bonetti, V Barresi, F Tatangelo, R Gafà, ... Cancers 11 (7), 1036, 2019 | 68 | 2019 |
| Cancer-associated immune resistance and evasion of immune surveillance in colorectal cancer P Parcesepe, G Giordano, C Laudanna, A Febbraro, M Pancione Gastroenterology research and practice 2016, 2016 | 66 | 2016 |
| Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer G Giordano, A Febbraro, E Tomaselli, ML Sarnicola, P Parcesepe, ... Journal of experimental & clinical cancer research 34, 1-11, 2015 | 66 | 2015 |
| Targeting angiogenesis and tumor microenvironment in metastatic colorectal cancer: role of aflibercept G Giordano, A Febbraro, M Venditti, S Campidoglio, N Olivieri, K Raieta, ... Gastroenterology research and practice 2014, 2014 | 66 | 2014 |
| Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer L Sabatino, M Pancione, C Votino, T Colangelo, A Lupo, E Novellino, ... World Journal of Gastroenterology: WJG 20 (23), 7137, 2014 | 64 | 2014 |
| Ensemble of gene signatures identifies novel biomarkers in colorectal cancer activated through PPARγ and TNFα signaling SM Pagnotta, C Laudanna, M Pancione, L Sabatino, C Votino, A Remo, ... PLoS One 8 (8), e72638, 2013 | 59 | 2013 |
| Prognostic role of β-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer M Pancione, N Forte, A Fucci, L Sabatino, A Febbraro, A Di Blasi, ... Human pathology 41 (6), 867-876, 2010 | 54 | 2010 |
| Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer A Remo, I Simeone, M Pancione, P Parcesepe, P Finetti, L Cerulo, ... Journal of translational medicine 13, 1-13, 2015 | 46 | 2015 |
| CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma D Pasquali, L Circelli, A Faggiano, M Pancione, A Renzullo, R Elisei, ... European Journal of Endocrinology 164 (3), 397-404, 2011 | 46 | 2011 |
| PPARG epigenetic deregulation and its role in colorectal tumorigenesis L Sabatino, A Fucci, M Pancione, V Colantuoni PPAR research 2012, 2012 | 43 | 2012 |
| Immune resistance and EGFR antagonists in colorectal cancer G Giordano, A Remo, A Porras, M Pancione Cancers 11 (8), 1089, 2019 | 41 | 2019 |
| Crosstalk between the tumor microenvironment and immune system in pancreatic ductal adenocarcinoma: potential targets for new therapeutic approaches P Parente, P Parcesepe, C Covelli, N Olivieri, A Remo, M Pancione, ... Gastroenterology research and practice 2018, 2018 | 39 | 2018 |
